Alopecia areata is an autoimmune condition in which the body’s own immune system attacks hair follicles, causing hair to fall out in round, smooth patches. It affects roughly 2% of the global population and can strike at any age, though most people develop their first patch before age 30. The hair loss itself is painless, and the follicles remain alive beneath the skin, which means regrowth is possible even after significant loss.
Why the Immune System Targets Hair Follicles
Hair follicles normally enjoy a form of biological protection called “immune privilege,” meaning the immune system mostly leaves them alone. In alopecia areata, that protection breaks down. A specific type of immune cell, known as a cytotoxic T cell, swarms the base of the hair follicle and shuts down hair production. These T cells release a signaling molecule called interferon-gamma, which further strips the follicle of its immune protection and triggers a self-reinforcing cycle: the more immune cells arrive, the more inflammation they generate, and the more follicles get pulled into the crossfire.
This loop is driven by two other immune signals, IL-2 and IL-15, which keep the attacking T cells active and multiplying. Understanding this chain reaction is what led researchers to develop targeted treatments that interrupt it.
What Causes It
There is no single cause. Alopecia areata arises from a combination of genetic susceptibility and environmental triggers, though pinpointing the exact trigger for any individual is often impossible. Many of the genes linked to the condition belong to the HLA (human leukocyte antigen) complex, a family of genes that helps the immune system distinguish the body’s own cells from foreign invaders. Certain variations in these genes appear to make the immune system more likely to misidentify hair follicles as a threat.
Beyond genetics, documented triggers include severe emotional stress, viral infections, physical trauma to the skin, and hormonal shifts. Having a close family member with alopecia areata increases your risk, and people with other autoimmune conditions are more likely to develop it as well. Thyroid disorders show the strongest overlap. In one clinical study, 18.3% of alopecia areata patients had a thyroid disorder, most commonly hypothyroidism. Vitiligo, atopic dermatitis (eczema), lupus, and type 1 diabetes also co-occur at higher-than-expected rates.
How Hair Loss Typically Appears
The most common pattern is one or more coin-sized bald patches on the scalp. The skin in these areas looks smooth and normal, without scarring, scaling, or redness. Patches can appear overnight or develop over a few days. Some people notice increased shedding on their pillow or in the shower before a bare spot becomes visible.
A hallmark sign is “exclamation point hairs,” short broken strands that are thinner at the base and wider at the top, resembling an exclamation mark. These appear at the edges of an active patch and signal that the immune attack is still progressing. Other visible clues include tiny black dots (broken hairs at the skin surface), yellow dots (plugged follicle openings), and fine, pale vellus hairs that may represent early regrowth.
Nail changes affect a smaller subset of patients. Tiny pits or dents across the nail surface are the most common finding, though roughly 4% of patients develop a rougher, sandpaper-like nail texture called trachyonychia. Nail involvement sometimes appears before any hair loss does.
The Different Patterns of Hair Loss
Alopecia areata exists on a spectrum. Most people experience patchy hair loss limited to a few spots on the scalp. When hair loss extends across the entire scalp, the condition is called alopecia totalis. When it involves the scalp, eyebrows, eyelashes, and body hair, it is called alopecia universalis. These are not separate diseases but rather degrees of the same underlying process.
The boundaries between these categories are blurry even among specialists. When 21 alopecia experts were asked to define totalis and universalis, their answers ranged from “90% scalp hair loss” to “100% scalp hair loss” for totalis, and from “any involvement beyond the scalp” to “not a hair anywhere” for universalis. In practice, your dermatologist will focus on the percentage of hair you’ve lost rather than assigning a rigid label.
How It Is Diagnosed
Diagnosis is usually straightforward. A dermatologist can often identify alopecia areata by looking at the pattern of hair loss and checking for exclamation point hairs at the edges of a patch. A handheld magnifying tool called a dermatoscope helps confirm the diagnosis by revealing characteristic features: black dots, broken hairs, yellow dots at follicle openings, and fine vellus hairs within the patch.
Blood tests are not required for diagnosis but may be ordered to check for thyroid problems or other autoimmune conditions that frequently accompany alopecia areata. A scalp biopsy is rarely needed and is typically reserved for cases where the pattern of loss is ambiguous or could be caused by something else, like scarring alopecia or a fungal infection.
Chances of Spontaneous Regrowth
Hair regrowth without any treatment is genuinely possible. Older estimates suggest that 34% to 50% of people with limited patchy alopecia areata regrow their hair within a year of onset. However, more recent data from clinical trial placebo groups paints a more conservative picture: only about 8% of patients with moderate-to-severe hair loss achieved meaningful regrowth on placebo, and near-complete regrowth was exceedingly rare at roughly 1.6%.
The difference likely reflects severity. People with just one or two small patches have the best odds of spontaneous recovery. Those with extensive loss, early onset in childhood, or involvement of eyebrows and eyelashes tend to follow a more persistent course. Even when hair does grow back, recurrence is common. Many people cycle through episodes of loss and regrowth over years or decades.
Treatment Options
Treatment depends on how much hair you’ve lost and how much it affects your quality of life. For a few small patches, many dermatologists start with steroid injections directly into the bald spots, repeated every three to four weeks for several months. This approach produces regrowth in roughly 75% to 80% of people with limited patches. Topical corticosteroids applied at home are a less invasive alternative, though they tend to be less effective on their own.
JAK Inhibitors for Severe Cases
The biggest shift in treatment has been the arrival of oral JAK inhibitors, which block the specific immune signals that fuel the attack on hair follicles. Three are now FDA-approved: baricitinib (Olumiant), approved in 2022 for adults; ritlecitinib (Litfulo), approved in 2023 for patients 12 and older; and deuruxolitinib (Leqselvi), approved in 2024. These medications are specifically indicated for severe alopecia areata, generally defined as 50% or more scalp hair loss.
Results vary. In large clinical trials of deuruxolitinib, about 31% of patients achieved substantial regrowth (less than 20% scalp hair loss remaining) by 24 weeks. JAK inhibitors work by interrupting the interferon-gamma and IL-15 signaling loop that sustains the immune attack. They are not a cure. Hair loss typically returns if the medication is stopped, so they require ongoing use. Side effects, cost, and insurance coverage are practical considerations that factor into whether these drugs are right for you.
Living With Alopecia Areata
Because the follicles are not destroyed, alopecia areata is fundamentally different from scarring forms of hair loss. The potential for regrowth remains even after years of baldness. But the unpredictability of the condition, not knowing whether a patch will spread or resolve, creates real psychological strain. Studies consistently find elevated rates of anxiety and depression in people with alopecia areata, particularly when eyebrow or eyelash loss changes facial appearance.
Practical options beyond medication include dermatographic eyebrow tattooing, medical-grade wigs (sometimes covered by insurance with a prescription), and eyelash adhesive strips. Support communities, both online and in person through organizations like the National Alopecia Areata Foundation, can help with the emotional side of a condition that is medically benign but personally significant.